New York v. Solvent Chemical Co.

214 F.R.D. 106, 2003 U.S. Dist. LEXIS 3916, 2003 WL 1249415
CourtDistrict Court, W.D. New York
DecidedFebruary 27, 2003
DocketNo. 83-CV-1401C
StatusPublished
Cited by4 cases

This text of 214 F.R.D. 106 (New York v. Solvent Chemical Co.) is published on Counsel Stack Legal Research, covering District Court, W.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
New York v. Solvent Chemical Co., 214 F.R.D. 106, 2003 U.S. Dist. LEXIS 3916, 2003 WL 1249415 (W.D.N.Y. 2003).

Opinion

CURTIN, District Judge.

Third-party plaintiffs Solvent Chemical Company, Inc. and ICC Industries, Inc. (collectively referred to herein as “Solvent”) have filed a joint motion pursuant to Fed. R.Civ.P. 26(c) for a protective order barring certain discovery sought by third-party defendant Olin Corporation (“Olin”) (Item 1178). Olin and third-party defendant General Motors Corporation have filed memoran-da in opposition to the motion (Items 1187 and 1188), and oral argument was heard by the court on January 10, 2003. For the following reasons, and to the extent discussed herein, the joint motion for a protective order is granted.

BACKGROUND

On October 29, 2002, Olin served a “Rule 30(b)(6) Deposition Notice and Rule 34 Request for Production of Documents” upon Solvent directing designation of a corporate representative to testify and produce documents pertaining to Solvent’s settlement agreements and negotiations with settling third-party defendants in this case (see Item 1181, Ex. A). By the parties’ reckoning, Solvent has reached settlements with twenty-eight third-party defendants to date.

In response to Olin’s discovery demand, Solvent’s counsel wrote a letter to Olin’s counsel on November 1, 2002 advising that the information sought by way of the deposi[108]*108tion notice and document demand was “inadmissible, privileged and irrelevant,” and inconsistent with the court’s prior rulings with regard to allocation of liability under the Uniform Comparative Fault Act (“UCFA”) (id., Ex. B). Specifically, by order dated October 8, 1997, this court ruled that Solvent’s private party contribution claims against non-settlors in this case are governed by the “proportionate share rule,” codified at Section 6 of the UCFA, which provides: “A release ... entered into by a claimant and a person liable discharges that person from all liability for contribution ... [and] the claim of the releasing person against other persons is reduced by the amount of the released person’s equitable share of the obligation.” State of New York v. Solvent Chemical Company, Inc., 984 F.Supp. 160, 166 (W.D.N.Y. 1997) (referred to by Solvent as the “First UCFA Order”). The court distinguished Solvent’s contribution claims from claims in eases which have applied the so-called “pro tanto” approach, codified at Section 4 of the Uniform Contribution Among Tortfeasors Act (“UCATA”), under which the liability of non-settling defendants is reduced by the dollar amount specified in the settlement agreement. Id. at 167-69. Subsequently, on June 3, 1999, the court granted Solvent’s motion to approve settlements with several third-party defendants upon finding that Section 6 of the UCFA “applies to all settlements with Solvent in this case ...” (Item 900, p. 2) (referred to by Solvent as the “Second UCFA Order”), and specifically rejecting General Motors’ argument that the other third-party defendants are entitled to know the specific terms of the settlement and the specific payment amount of each settling third-party defendant (id.).

Solvent contends that the application of the UCFA and the UCFA Orders have rendered the information sought by Olin irrelevant because the amount Solvent may recover from the non-settling parties will be reduced by the aggregate of the equitable shares of the settling third-party defendants, not by the total dollar amount they actually paid in settlement. According to Solvent, the assignment of the settling parties’ equitable shares will be a matter of expert testimony, and Olin and the other non-settlors will be able to inquire into the basis of the expert testimony at the appropriate time. Solvent also contends that designation of an officer pursuant to Rule 30(b)(6) to testify on its behalf with regard to settlement matters will unnecessarily embroil the parties in attorney-client privilege issues. According to Solvent, the settlement negotiations were conducted primarily by litigation counsel from Jaeckle, Fleisch-mann & Mugel, who drafted and executed the settlement agreements on Solvent’s behalf and only communicated with Solvent’s General Counsel, Paul Falick, for approval after a tentative settlement had been reached.

Olin and General Motors respond that in order to properly prepare to question Solvent’s allocation expert, they must be permitted to discover the dollar amount each third-party defendant settled for, the negotiations leading up to each settlement agreement, and the agreements themselves. The non-set-tlors argue that this information is relevant to the equitable share determination, as indicated by the court’s holding in the October 8, 1997 order that the UCFA approach is appropriate because “the other parties are entitled to a precise determination of their equitable share before anteing up.” Solvent Chemical, 984 F.Supp. at 169.

DISCUSSION

As discussed, Solvent asserts two general grounds in support of its request for a protective order: (1) that the information sought is irrelevant in light of the court’s UCFA Orders, and (2) that the Rule 30(b)(6) notice threatens the attorney-client privilege. Each of these grounds is discussed in turn.

1. Relevance of Settlement Information

As set forth at length in this court’s October 8, 1997 order, where the defendant in a CERCLA action has resolved its liability with the government, the liability of non-settling third-party defendants is determined by private party contribution claims brought under CERCLA § 113(f)(1). In resolving contribution claims under this section, “the court may allocate response costs among lia[109]*109ble parties using such equitable factors as the court determines are appropriate.” 42 U.S.C. § 113(f)(1); Solvent Chemical, 984 F.Supp. at 166; see also Kerr-McGee Chemical Corporation v. Lefton Iron & Metal Company, 14 F.3d 321, 326 & n. 4 (7th Cir.1994) (listing equitable factors courts may consider, including so-called “Gore factors”1). The majority of courts undertaking allocation under Section 113(f)(1) have applied the “proportionate share rule” of Section 6 of the UCFA, which reduces a non-settlor’s liability by the amount of the settlor’s equitable share of the obligation, as determined at trial. Id.

Under this approach, “a non-settling party may offset its liability by a settling party’s equitable share of liability. The effect of this provision is to impose upon the claimant who settles with a party — rather than upon a non-settling party — the risk that the settlement amount is disproportionately small.” United States v. GenCorp, Inc., 935 F.Supp. 928, 932 (N.D.Ohio 1996) (cited with approval by this court in its June 3, 1999 order). Based on this rationale, in the context of judicial determination of the fairness of settlements between and among more than two dozen parties in the case, the court in GenCorp denied a non-settling third-party defendant’s request for disclosure of the financial terms of the individual settlements. The court stated:

While disclosure of settlement amounts and allocations of liability is the norm, the Court is not convinced it is a sine qua non of a finding of fairness and reasonableness.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
214 F.R.D. 106, 2003 U.S. Dist. LEXIS 3916, 2003 WL 1249415, Counsel Stack Legal Research, https://law.counselstack.com/opinion/new-york-v-solvent-chemical-co-nywd-2003.